Sena Alaeikhanehshir

In July 2017, I finished my last medical internship at the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital at the Department of Surgery and received my MD from the University of Amsterdam - Academic Medical Centre (UVA-AMC). During this internship, I came to know dr. Wesseling as the lead investigator and study coordinator of the LORD trial. This trial aims to test whether active surveillance of screen-detected low-grade DCIS, a commonly found lesion considered as a potential precursor of breast cancer, is as safe as conventional treatment. I was selected as MD PhD student focusing on further initiation, implementation and analysis of the trial.